Dr. King Discusses Approaches to Lymphedema in Breast Cancer

Tari King, MD, FACS
Published: Friday, Mar 09, 2018



Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses approaches to treating lymphedema in patients with breast cancer.

Investigators have been studying the effects of not removing additional lymph nodes in patient with breast cancer. Both observation and axillary radiotherapy have been proven to be effective and have lower rates of lymphedema than axillary node dissection, says King, although many providers prefer to avoid radiation, if possible.

Women who do not have additional surgery do not have to see their physician or undergo extra testing as often as those who do undergo additional surgery, as the rate of axillary recurrence is so low. These patients only require standard surveillance due to this low event rate, says King.


Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses approaches to treating lymphedema in patients with breast cancer.

Investigators have been studying the effects of not removing additional lymph nodes in patient with breast cancer. Both observation and axillary radiotherapy have been proven to be effective and have lower rates of lymphedema than axillary node dissection, says King, although many providers prefer to avoid radiation, if possible.

Women who do not have additional surgery do not have to see their physician or undergo extra testing as often as those who do undergo additional surgery, as the rate of axillary recurrence is so low. These patients only require standard surveillance due to this low event rate, says King.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Publication Bottom Border
Border Publication
x